Oesophageal post-therapy myeloid sarcoma masquerading as poorly differentiated adenocarcinoma: a diagnostic pitfall

Histopathology. 2022 Feb;80(3):604-606. doi: 10.1111/his.14538. Epub 2021 Sep 20.

Authors

Dipti M Karamchandani¹, Pauline Go², Michael Bayerl¹, Kunal Karamchandani³

Affiliations

¹ Division of Anatomic Pathology, Department of Pathology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
² Division of Thoracic Surgery, Department of Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
³ Department of Anesthesiology and Perioperative Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.

PMID: 34355418
DOI: 10.1111/his.14538

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / pathology
Adenocarcinoma / therapy*
Aged
Antineoplastic Agents / adverse effects
Esophageal Neoplasms / pathology
Esophageal Neoplasms / therapy*
Esophagectomy
Humans
Leukemia, Myeloid, Acute / chemically induced*
Leukemia, Myeloid, Acute / diagnosis
Male
Neoplasms, Second Primary / chemically induced*
Sarcoma, Myeloid / chemically induced*

Substances

Antineoplastic Agents